The NOXCOVID Phase I trial is likely to proceed at warp speed.
- Let’s say the first dose is 1200 mg per day – known to be safe. Cytokine measurement presumably taken every day, so perhaps five days to determine whether 1200 mg NOX66 reduces cytokine levels by a significant amount.
- If a better response is needed, increase the daily dose of NOX66 to say 2400mg.
- If necessary, increase the dose to 3600 mg per day
- Do this in parallel in six hospitals, with say two patients at a time on the same dose, and complete cytokine data for 36 patients could be known within 15 treatment days
- Allow a factor of safety of 100%, so one perhaps one month in all.
I read recently that in the COVID environment, trial results can be released before they go through a peer-review process. The price action today suggests to me that investors don’t want to be left behind if results are released sooner rather than later.
- Forums
- ASX - By Stock
- Timing
The NOXCOVID Phase I trial is likely to proceed at warp speed....
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.7¢ |
Change
0.001(1.52%) |
Mkt cap ! $19.57M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.7¢ | $818 | 12.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17790 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 4049 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17790 | 0.067 |
1 | 24715 | 0.066 |
1 | 15000 | 0.065 |
1 | 10000 | 0.064 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 4049 | 1 |
0.079 | 11999 | 1 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.090 | 52000 | 3 |
Last trade - 15.44pm 12/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |